Combination Products Forum

GBC 7

Combination Products Forum

10:00 ~ 15:30 GB III 5F

Summary
We anticipate the future outlook in the industry beyond the existing definitions and regulations in line with the rapid advancement of medical technologies. We also talk about the prospects for regulations and developments pertaining to cutting edge technologies.
Date
June 29(Fri), 10:00 ~ 15:30
Venue
GB III 5F Venue Guide

Schedule

Time Title Presentation File
Combination Products Forum
Keynote Speech
10:00~10:40(40')

From Lab to Life – Convergence of technology and healthcare in a seamless society

Tobias Daniel Gantner / Healthcare Futureists GmbH

[Session 1] Regulatory Trends | Chair : Jin Hyung Shim (Korea Polytechnic University)
10:40~11:20(40')

Classification of ATMP in EU: Combined Products and Borderline Issues

Ralf Sanzenbacher /
Paul-Ehrlich-Institut / EMA-CAT

11:20~12:00(40')

Combination Products: A Recent FDA Perspective

Sugato De / Parexel Consulting

[Session 2] Development Trends | Chair : Sung Min Kim (Dongguk University)
13:00~13:30(30')

3D Hybrid Bioprinting Technology for Artificial Organ Regeneration

Hyun-Wook Kang / Ulsan National Institute of Science and Technology

13:30~14:00(30')

Digital Transformational in Regulatory Operations

Shimon Yoshida / Pfizer

14:00~14:30(30')

AI driven Healthcare Innovation

Uhn Lee / Gachon University Gil Medical Center

14:30~15:00(30')

Global Regulation of Companion Diagnostics

Tracy Bush / Roche Diagnostics, Inc.

15:00~15:30(30')

Using Convergence Technology in novel anticancer drug development: Challenges and Prospects

Youn Soo Sohn / CNPharm